Is the nocturnal fall in blood pressure reduced in essential hypertensive patients with metabolic syndrome?
- 1 January 2004
- journal article
- Published by Informa UK Limited in Blood Pressure
- Vol. 13 (4), 230-235
- https://doi.org/10.1080/08037050410021540
Abstract
Objective: The aim of this study was to examine whether an impaired reduction in nocturnal blood pressure (BP), defined on the basis of two periods of ambulatory BP monitoring (ABPM), is present in hypertensive patients with metabolic syndrome, as defined by the NCEP criteria. Methods: 460 grade 1 and 2 untreated essential hypertensives (mean age 45.9 ± 11.9 years) referred for the first time to our outpatient hospital clinic underwent the following procedures: 1) medical history and physical examination; 2) repeated clinic BP measurements; 3) routine examinations; 4) ABPM over two 24‐hour periods within 4 weeks. Metabolic syndrome was defined as at least three of the following alterations: increased waist circumference, increased triglycerides, decreased HDL‐cholesterol, increased BP, or high fasting glucose. Nocturnal dipping was defined as a night‐time reduction in average SBP and DBP >10% compared to average daytime values. Results: The 135 patients with metabolic syndrome (group I) were similar for age, gender and known duration of hypertension to the 325 patients without it (group II). There were no significant differences between the two groups in average 48‐hour, daytime, night‐time SBP/DBP values and the percentage nocturnal SBP and DBP decrease (−17.7/−15.7 vs.−18.4/−16.2, p = ns). A reproducible nocturnal dipping (decrease in BP >10% from mean daytime in both ABPM periods) and non‐dipping profile (decrease in BP ≤10% in both ABPM periods) was found in 74 (54.8%) and 29 (21.4%) in group I and in 169 (52.1%) and 73 (22.4%) in group II, respectively (p = ns); 32 patients (23.7%) in group I and 83 patients (25.5%) in group II had a variable dipping profile (p = ns). Conclusions: This study shows that no significant difference exists in nocturnal BP patterns, assessed by two ABPMs, in untreated essential hypertensive patients with metabolic syndrome compared to those without it.Keywords
This publication has 23 references indexed in Scilit:
- Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressureJournal Of Hypertension, 2004
- NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and OlderDiabetes, 2003
- Impact of Glucose Intolerance and Insulin Resistance on Cardiac Structure and FunctionCirculation, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Cardiovascular Morbidity and Mortality Associated With the Metabolic SyndromeDiabetes Care, 2001
- Glucose Tolerance and Cardiovascular MortalityArchives of Internal Medicine, 2001
- Effect of Type 2 Diabetes Mellitus on Left Ventricular Geometry and Systolic Function in Hypertensive SubjectsCirculation, 2001
- Syndrome X and Mortality: A Population-based StudyAmerican Journal of Epidemiology, 1998
- Prospective analysis of the insulin-resistance syndrome (syndrome X)Diabetes, 1992
- Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension.Circulation, 1990